Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-04-26
2011-04-26
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S053000, C514S061000, C536S017400, C536S123100, C435S085000
Reexamination Certificate
active
07932236
ABSTRACT:
Novel synthetic gangliosides and pharmaceutical compositions containing such synthetic gangliosides are described. Methods of making the novel synthetic ganglioside compounds and compositions as well as their use in the field of neuroprotection is also described.
REFERENCES:
patent: 3954881 (1976-05-01), Bowler
patent: 4940694 (1990-07-01), della Valle et al.
patent: 5264424 (1993-11-01), Della Valle et al.
patent: 5409817 (1995-04-01), Ito et al.
patent: 5922577 (1999-07-01), Defrees et al.
patent: 6060526 (2000-05-01), Tasaki
patent: 6413935 (2002-07-01), Sette et al.
patent: 6440703 (2002-08-01), DeFrees
patent: 2001/0041683 (2001-11-01), Schmitz et al.
patent: 2005/0032742 (2005-02-01), DeFrees et al.
patent: 2005/0245735 (2005-11-01), DeFrees
patent: 197 09 787 (1998-09-01), None
patent: 0 119 539 (1984-12-01), None
patent: 0577580 (1994-01-01), None
patent: 0 577 580 (1994-10-01), None
patent: 9208461 (1997-08-01), None
patent: WO 93/18787 (1993-09-01), None
patent: WO 98/40390 (1999-01-01), None
patent: WO 99/28491 (1999-06-01), None
patent: WO 00/046379 (2000-08-01), None
patent: WO 03/011879 (2003-02-01), None
patent: WO 03/016469 (2003-02-01), None
patent: WO 03/017949 (2003-03-01), None
patent: WO 2004/080960 (2004-09-01), None
The Merck Manual, 16th Edn. 1992, pp. 1403-1404 and 1488-1489.
Alais et al., “Synthesis of linear tetra-, hexa-, and octa-saccharide fragments of the i-blood group active poly-(N-acetyl-lactosamine) series, etc.,” Carbohydrate Research, vol. 207, 1990, pp. 11-31.
Beith-Halahmi et al., Carbohydrate Research, vol. 5, 1967, pp. 25-30.
Bertozzi, C.R., et al., “Carbon-Linked Galactosphingolipid Analogs Bind specifically to HIV-1 gp120,”J. Am. Cchem. Soc., 1992, vol. 114, No. 26, pp. 10639-10641.
Binder, W.H., et al., “Galactosylation by Use of B-Galactosidase Chemo-Enzymatic Syntheses of Di and Trisaccharides,”Tetrahedron, 1994, vol. 50, No. 35, pp. 10407-10418.
De Rosa, S., et al., “Aliphatic and Aromatic Glycosides from the Cell Cultures ofLycopersicon esculentum,” Phytochemistry, 1996, vol. 42, No. 4, pp. 1031-1034.
Dreyfus et al., “Successive isolation and separation of the major lipid fractions including gangliosides from single biological samples.” Anal. Biochem., vol. 249,1997, pp. 67-78.
Fleischer, S. and Packer, L., eds. “Glycosphingolipid from animal cell membranes.” Ch. 33 in Methods in Enzymology , vol. XXXII, Biomembranes, 1974. Academic Press: New York, NY, pp. 345-367.
Guivisdalsky, P.N., et al., Synthesis and Antineoplastic Properties of Ether-Linked Thioglycolipids,J. Med. Chem., 1990, vol. 33, No. 9, pp. 2614-2621.
Grundler et al., Carbohydrate Research, vol. 135, 1985, pp. 203-218.
Guadino et al., Jour. Amer. Chem. Soc., vol. 116, 1994, pp. 1149-1150.
Hakomori et al, “Isolation and Characterization of Glycosphingolipid from Animal Cells and their Membranes.” Methods in Enzymology, vol. 32, 1974, pp. 345-367.
Hasegawa et al., J. Carbohydrate Chem., vol. 10, 1991, pp. 439-459.
Helling, et al., “GD3 Vaccines for Melanoma: Superior Immunogenicity of Keyhole Limpet Hemocyanin Conjugate Vaccines,” Cancer Research, Jan. 1, 1994, vol. 54, pp. 197-203.
Ito, et al., “A Novel Strategy for Synthesis of Ganglioside GM# using an Enzymatically Produced Sialoside Glycosyl Donor.” Jour. of Amer. Chem. Soc., vol. 115, No. 4, 1993, pp. 1603-1605.
Jenneman, et al., “Specific Immunization Using Keyhole Limpet Hemocyanin Conjugate Vaccines.” Journal of Biochemistry, vol. 115, No. 6, 1994, pp. 1047-1052.
Kameyama et al., Carbohydrate Research, vol. 193, 1989, pp. cI-c5.
Kawai et al., “Structure of Biologically Active and Inactive Cerebrosides Prepared from Schizophyllim Commune,” Journal of Lipid Research, vol. 26, 1985, pp. 338-343.
Koike, K., et al., “Total Synthesis of Cerebroside: (2S, 3R, 4E)-1-0-B-D-Galactopyranosyl-N(2′R and 2′S)-2′-Hydroxytetracosanoylsphingenine,”Carbohydrate Research, 1987, vol. 162, pp. 237-246.
March, Jerry. March's Advanced Organic Chemistry, Fourth Edition, 1992. Wiley-Interscience: Hoboken, NJ, pp. 383-386.
Marinier A., et al., “Sulfated Galactocerebrosides as Potential Antiinflammatory Agents,”J. Med. Chem., 1997, vol. 40, No. 20, pp. 3234-3247.
Morrison, “Polar Lipids in Bovine Milk.” Biochimica et Biophysica Acta, vol. 176, 1969, pp. 537-546.
Murase et al., Carbohydrate Research, vol. 188, 1989, pp. 71-80.
Paulsen et al., Carbohydrate Research, vol. 137, 1985, pp. 39-62.
Pfäffli, P.J., et al., “Thioglycosides Having 0-Benzyl Blocking Groups as Intermediates for the Systematic, Sequential Synthesis of Oligosaccharides. Synthesis of isomaltose,”Carbohydrate Research, 1972, vol. 23, pp. 195-206.
Ponpipom et al, Tetrahedron Letters, 1978, pp. 1717-1720.
Probert, et al., “Chemoenzymatic Synthesis of GM3, Lewis x and Sialyl Lewis x Olgosaccarides in13C-Enriched Form,” Tetrahedron Letters, vol. 38, No. 33, 1997, pp. 5861-5864.
Schwarzmann et al, Meth. Enzymol, vol. 138, 1987, pp. 319-341.
Sogin, David C., et al. “Binding of Cytochalasin B to human Erythrocyte Glucose Transporter,”Biochemistry, 1980, vol. 19, No. 23, pp. 5417-5420.
Suzuki, Y. “Gangliosides as influenza virus receptors. Variation of influenza viruses and their recognition of the receptor sialo-sugar chains.” Prog. Lipid. Res. vol. 33, No. 4, pp. 429-457, 1994.
Tsujihara, K., “A new class of Nitoureas. II synthesis and Antitumor Activity of 1-(2Chloroethyl)-3,3,Disubstituted-1nitrsoureas having a Glucopyranosyl, Mannopyranosyl or Galactopryanosyl Moiety,”Chem. Pharm. Bull., 1981, vol. 29, No. 11, pp. 3262-3273.
Yoshikawa, K., et al., “Aroma Glycosides fromHovenia dulsis,” Phytochemistry, 1993, vol. 34 No. 5, pp. 1431-1433.
Zehavi et al., “Enzymic Glycosphingolipid Synthesis on Polymer Supports. II. Synthesis of Lactosyl Ceramide.” Glycoconjugate Journal, vol. 7, 1990, pp. 229-234.
Zhang et al., Anticancer Research, vol. 15, 1995, pp. 661-666.
DeFrees Shawn
Wang Zhi-guang
Jiang Shaojia Anna
Krishnan Ganapathy
Morgan & Lewis & Bockius, LLP
Seneb Biosciences, Inc.
LandOfFree
Glycolipids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycolipids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycolipids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2719074